Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. back pain
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Books
Downloads
Videos

Refine by
Date

  • This month
  • This Year
  • Older

Back Pain Articles & Analysis

86 news found

The Truth About Ergonomics in Loupes: A Comprehensive Response to Other Loupe Manufacturer Claims

The Truth About Ergonomics in Loupes: A Comprehensive Response to Other Loupe Manufacturer Claims

This assertion focuses on the benefits of refractive loupes with deflection prism, positioning them as the exclusive solution for chronic neck and back pain in dental professionals.5 However, while refractive loupes can improve posture by using refractive or deflection prisms to maintain neutral neck positions, they are not the only or the most effective solution ...

BySurgiTel is a Division of General Scientific Corporation (GSC)


Enhancing Ergonomics for Dentists and Surgeons: Promoting Health, Efficiency, and Career Longevity

Enhancing Ergonomics for Dentists and Surgeons: Promoting Health, Efficiency, and Career Longevity

However, inadequate ergonomics can result in chronic pain, musculoskeletal disorders (MSDs), fatigue, and shortened careers, with studies indicating that up to 80% of these professionals suffer from work-related pain, such as lower back discomfort, neck stiffness, or carpal tunnel syndrome.1-2 By adopting ergonomic practices, these healthcare ...

BySurgiTel is a Division of General Scientific Corporation (GSC)


Tris Pharma Presents Data Reinforcing Limited Abuse Potential of Investigational Pain Therapy Cebranopadol at the 2023 PAINWeek Conference

Tris Pharma Presents Data Reinforcing Limited Abuse Potential of Investigational Pain Therapy Cebranopadol at the 2023 PAINWeek Conference

“Given that the opioid epidemic continues to have a devastating impact on a global scale and millions of people live each day with pain that is not well managed, the importance of developing novel safe and effective pain management therapies cannot be overstated,” said Ketan Mehta, founder and chief executive officer at Tris Pharma. “The data ...

ByTris Pharma, Inc.


Meagan Medical Inc. Announces Issuance of a Key U.S. Patent for a Disruptive Chronic Pain Treatment using Spinal Cord Stimulation

Meagan Medical Inc. Announces Issuance of a Key U.S. Patent for a Disruptive Chronic Pain Treatment using Spinal Cord Stimulation

Patent provides protection for High Frequency Spinal Cord Stimulation with Beat Technology Vancouver, Washington – March 20, 2015 – Meagan Medical Inc., a clinical research and medical device development company focused on investigating and developing optimal ways of managing and controlling pain, announced today the issuance of a key patent ...

ByMeagan Medical, Inc.


Tris Pharma Reports Positive Topline Data from Clinical Study of Investigational Pain Therapy Cebranopadol Showing Significantly Less Potential for Abuse Versus Tramadol and Oxycodone

Tris Pharma Reports Positive Topline Data from Clinical Study of Investigational Pain Therapy Cebranopadol Showing Significantly Less Potential for Abuse Versus Tramadol and Oxycodone

Cebranopadol is a novel, dual nociceptin/orphanin FQ peptide (NOP) receptor and ÎĽ-opioid peptide (MOP) receptor agonist in development for the treatment of moderate to severe pain. Multiple clinical studies have demonstrated that cebranopadol is efficacious in different types of pain. ...

ByTris Pharma, Inc.


Differences Between Spinal Blocks & Epidurals

Differences Between Spinal Blocks & Epidurals

The biggest difference between spinal blocks vs epidurals is their amount of pain relief: spinal blocks provide total pain relief, while epidurals provide partial pain relief. ...

ByMilestone Scientific, Inc.


Alnylam Presents Additional Results from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy at Heart Failure Society of America Annual Meeting

Alnylam Presents Additional Results from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy at Heart Failure Society of America Annual Meeting

– New Data Further Support Potential for Patisiran to be an Effective Treatment for Cardiomyopathy of ATTR Amyloidosis – – Data from Exploratory Endpoints, Including Cardiac Biomarkers and Imaging, Suggest Favorable Impact of Patisiran on Measures of Cardiac Stress, Injury, Structure, and Function at Month 12 – – Treatment with Patisiran Demonstrated Generally ...

ByAlnylam Pharmaceuticals, Inc.


Creative Medical Technology Announces Positive Top-Line Results for StemSpine Pilot Study

Creative Medical Technology Announces Positive Top-Line Results for StemSpine Pilot Study

("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology, and orthopedics, today announced positive two-year follow-up data for the Company's StemSpine® pilot study, showing significant efficacy of the StemSpine® procedure for treating chronic lower ...

ByCreative Medical Technology Holdings, Inc. (CELZ)


What to Expect for an Epidural Injection

What to Expect for an Epidural Injection

Roughly 8% of U.S. adults suffer from persistent or chronic back pain. That’s around 65 million people who are prevented from engaging in daily activities. ...

ByMilestone Scientific, Inc.


Creative Medical Technology Announces Peer Reviewed Publication of Positive Results for StemSpine Study

Creative Medical Technology Announces Peer Reviewed Publication of Positive Results for StemSpine Study

("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, neurology, and orthopedics, today announced the peer reviewed publication of positive, two-year follow-up data for the Company's StemSpine® study, showing significant efficacy of the StemSpine® procedure for treating ...

ByCreative Medical Technology Holdings, Inc. (CELZ)


Flowonix Medical Inc. And Cerebral Therapeutics Announce World-First Clinical Trial Delivering Medication Directly Into The Brain For Patients With Refractory Epilepsy

Flowonix Medical Inc. And Cerebral Therapeutics Announce World-First Clinical Trial Delivering Medication Directly Into The Brain For Patients With Refractory Epilepsy

Flowonix Medical Inc. of New Jersey, and Colorado-based Cerebral Therapeutics, announced today the first patients implanted with the Prometra II Programmable Infusion System in the Australian Direct Drug Administration for Refractory Epilepsy (ADDRESS) clinical trial at St. Vincent's Hospital, Melbourne, Australia. The jointly developed therapy features a micro-infusion device that tightly ...

ByFlowonix Medical Inc.


Alnylam to Present Additional Data from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy at the Heart Failure Society of America Annual Scientific Meeting 2022

Alnylam to Present Additional Data from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy at the Heart Failure Society of America Annual Scientific Meeting 2022

– Company to Webcast Investor Event on September 30th at 8:00 p.m. ET – CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sep. 13, 2022-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the Company will present additional data from the APOLLO-B Phase 3 study of patisiran, an investigational RNAi therapeutic in development for the treatment ...

ByAlnylam Pharmaceuticals, Inc.


Possible Side Effects of Local Anesthesia

Possible Side Effects of Local Anesthesia

If you’ve ever had an injection by a dentist, you’ve had a local anesthetic. Fast-acting, virtually pain-free and convenient, local anesthetics enable much of medicine to occur. ...

ByMilestone Scientific, Inc.


Know your Pain Management Options During Labor

Know your Pain Management Options During Labor

Intrathecal Narcotic (ITN) One of the lesser known labor pain relief managers, intrathecal narcotic, is delivered via a shot into the lower back. ...

ByMilestone Scientific, Inc.


Robotic innovation delivers relief for back pain sufferers

Robotic innovation delivers relief for back pain sufferers

An innovation that automates the diagnosis and treatment of chronic back pain could bring benefits to millions of patients, increase work productivity and provide therapists with a time-saving ...

ByAdamo Robot


In the hands of ADAMO Robot

In the hands of ADAMO Robot

The clinical trials conducted by La Rioja’s healthcare service demonstrates the effectiveness of the only therapeutic massage robotic device that uses pressurized air to treat back pain. ...

ByAdamo Robot


Physiotherapy for back pain with a contactless AI robot - Spain Adamo Robot

Physiotherapy for back pain with a contactless AI robot - Spain Adamo Robot

The protocol for the treatment of chronic back pain is difficult to establish, but certain results of physical therapy are expected. ...

ByAdamo Robot


The future of precise personalised robotic physiotherapy

The future of precise personalised robotic physiotherapy

The essence of this new medical advance is to improve access to physical therapy for people with chronic back pain. The EU-funded ADAMO Robot project is developing a robotic arm that provides precise therapeutic treatment by applying compressed air to a patient’s back. ...

ByAdamo Robot


Adamo, the world’s first collaborative physiotherapist robot, was born in Spain and his massages are that good

Adamo, the world’s first collaborative physiotherapist robot, was born in Spain and his massages are that good

Back pain is one of the most important and frequent ailments in our society, appearing with greater incidence after the age of 30, and also more and more frequently in children, since they acquire bad conditions throughout their development. postures when sitting, bending over, walking… Although now it is more common due to the enormous ...

ByAdamo Robot


Landmark Survey by Stagwell`s The Harris Poll Estimates More Than 72.3 Million U.S. Adults Suffer from Chronic Low Back Pain - Greater than Arthritis, Diabetes, or Heart Disease and with Debilitating Impact on Quality of Life

Landmark Survey by Stagwell`s The Harris Poll Estimates More Than 72.3 Million U.S. Adults Suffer from Chronic Low Back Pain - Greater than Arthritis, Diabetes, or Heart Disease and with Debilitating Impact on Quality of Life

Significant Drop in Mobility Due to Chronic Low Back Pain (CLBP) Demonstrated in New Mobility Index, with Highest Drop Among Those in Their 50s Treatment is Deficient with 15% Currently Taking Opioids Despite CDC Guidelines Noting Inadequate Effectiveness and Inherent Risks Only 5% Utilizing Recommended Minimally Invasive Treatment Options The Harris ...

ByVertos Medical, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT